Swedish medical products and solutions company Mölnlycke has announced the acquisition of M&J Airlaid Products A/S strengthening its wound care capabilities.
Mölnlycke acquires M&J Airlaid Products
Credit: Mölnlycke
Danish company M&J manufacture specialised and high-quality absorbent airlaid non-woven materials. This airlaid technology is a critical component, along with soft silicone and foams, in Mölnlycke's wound care products. M&J has an annual revenue of €10 million and this acquisition is part of Mölnlycke's growth strategy, also adding critical R&D capabilities to the product pipeline.
The acquisition will also improve the security of supply for Mölnlycke, as well as growing the company's wound care business through the acceleration of innovation and product development in both existing and future products. Mölnlycke and M&J have agreed to keeping the purchase price confidential.
Mölnlycke CEO Richard Twomey said "we are very happy to welcome M&J into the Mölnlycke family. Our relationship dates back several decades, and thus is a natural unification of forces. This is fully in line with where we want to be as a company, and M&J’s strong R&D capabilities combined with Mölnlycke’s end-product knowledge will help us further improve our competitive position within the advanced wound care industry."
M&J CEO Jens Ole Brøchner said: "I welcome Mölnlycke, a long-time customer and partner of M&J, to care for our heritage. The operational and strategic synergies will allow for high-quality products brought to market even faster, and I look forward to continued success under the new ownership structure."
Back to Homepage
Back to Healthcare